Gina Simmons Chapman’s Post

WATCH: Expert oncologists reflect on the evolving treatment paradigm for KRAS-mutated mNSCLC w/ insight into data from #ESMO23, discussing targeted therapies and future perspectives in clinical practice. #oncology https://lnkd.in/eNrw_tyq

How will the clinical data presented at #ASCO24, #EHA24, and #WCGI24 impact cancer care? We have the clinical and practice-changing insights! Get our EPICS insights reports: https://lnkd.in/eGj4rEGF #hematology #oncology

Chemotherapy is a powerful tool in the fight against cancer, but it often comes with significant side effects. One way to control these effects is through the use of chemoprotectants. Ensuring the appropriate dose of these protective agents is crucial for maximizing their benefits and minimizing complications. Let's prioritize research and innovation in this area to improve patient outcomes and quality of life. #Oncology #CancerTreatment #Chemoprotectants #PatientCare #MedicalResearch

Join Dr. Samuel Kareff in an enlightening Fellows Forum interview with Dr. Gilberto Lopes, Chief of the Division of Medical Oncology at the University of Miami's Sylvester Comprehensive Cancer Center. Dr. Lopes shares insights into his work in global oncology, the rise of sustainable development goals, and the critical importance of equity in healthcare. Discover the organizations dedicated to democratizing drug access globally and delve into recent research addressing outcome disparities. 🔗 Watch the full interview here: https://bit.ly/4cR9AxZ #GlobalOncology #MedicalResearch #Healthcare #Oncology #ProfessionalDevelopment

Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/dWAJ2m6m #MedicalImaging #ClinicalTrials #ChooseCalyx #ESMO2023 

Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/gSU8VX7W #MedicalImaging #ClinicalTrials #ChooseCalyx #ESMO2023 

Embrace Adaptive Therapy: P-Cure stands for the commitment to innovation and personalized treatment approaches. Our cutting-edge system grants the power to execute adaptive therapy with unparalleled precision, realizing the vision without the usual time-consuming steps found in other platforms. This isn't just adaptive therapy; it's the highly profitable future you've been waiting for and showing unprecedented ROI. P-Cure's proton therapy is changing the way patients are treated for cancer. Hadassah Medical Center #protontherapy #cancercare #oncology

Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/d6VTjJCW #MedicalImaging #ClinicalTrials #ChooseCalyx #ESMO2023 

Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/eUJ7ER5y #MedicalImaging #ClinicalTrials #ChooseCalyx #ESMO2023 

Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/dJs-yd3T #MedicalImaging #ClinicalTrials #ChooseCalyx #ESMO2023